If you buy something, we may earn an affiliate commission. That’s not for us to say (or judge), but if you’ve heard about ...
Emergent BioSolutions Inc. (NYSE: EBS) today announced the exercise of contract option and modification valued at approximately $20 million to supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S.